TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan adds generic Detrol, HIV/AIDS drugs

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

MYL $27.29 +$0.10

at close on THURSDAY

Daily Photo Galleries

Thursday, Nov. 29, 2012, 12:40 p.m.
 

Mylan Inc. said on Thursday that it had introduced a generic incontinence drug to the U.S. market and was selected by the South African government as a supplier of antiretroviral drugs.

Cecil-based Mylan has started selling Tolterodine Tartrate tablets, the generic version of Detrol, made by Pfizer Inc. Tolterodine Tartrate had U.S. sales of $61.5 million for the 12 months ended Sept. 30.

The company said the South African National Department of Health selected Mylan's Indian subsidiary to supply it with 31 percent of the 30 million units of HIV/AIDS drugs it will buy in a two-year period ending Dec. 31, 2014.

Mylan's share of the contract is valued at about $127.5 million.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Stories

  1. Georgia Tech runs all over mistake-prone Pitt
  2. Predators GM Poile: Penguins’ firing of Shero not fair
  3. NFL notebook: Bucs DT McCoy signs 7-year, $98M deal
  4. Masontown bakery owner hopes for recipe for success
  5. Pirates acquire infielder from Indians, designate Axford, Gomez for assignment
  6. Fay-West food banks feeling hunger pains
  7. Komen acceptance of drilling-linked money raises ire
  8. Linebacker Harrison coming along slowly since return to Steelers
  9. WWII pilot takes off in B-29 yet again
  10. Armstrong in test program using slag on icy roads
  11. New software expected to help Butler County collect fees
Subscribe today! Click here for our subscription offers.